These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 3906918)
1. Studies on the chemotherapy of human opisthorchiasis: effective dose of praziquantel in heavy infection. Pungpak S; Bunnag D; Harinasuta T Southeast Asian J Trop Med Public Health; 1985 Jun; 16(2):248-52. PubMed ID: 3906918 [TBL] [Abstract][Full Text] [Related]
2. Studies on the chemotherapy of human opisthorchiasis: III. Minimum effective dose of praziquantel. Bunnag D; Harinasuta T Southeast Asian J Trop Med Public Health; 1981 Sep; 12(3):413-7. PubMed ID: 7342331 [TBL] [Abstract][Full Text] [Related]
3. Opisthorchis viverrini: clinical experience with praziquantel in Hospital for Tropical Diseases. Bunnag D; Pungpark S; Harinasuta T; Viravan C; Vanijanonta S; Suntharasamai P; Migasena S; Charoenlarp P; Riganti M; LooAreesuwan S Arzneimittelforschung; 1984; 34(9B):1173-4. PubMed ID: 6542386 [TBL] [Abstract][Full Text] [Related]
4. Field trial of praziquantel in human opisthorchiasis in Thailand. Supanvanich S; Supanvanich K; Pawabut P Southeast Asian J Trop Med Public Health; 1981 Dec; 12(4):598-602. PubMed ID: 7344110 [TBL] [Abstract][Full Text] [Related]
5. Studies on the chemotherapy of human opisthorchiasis in Thailand: I. Clinical trial of praziquantel. Bunnag D; Harinasuta T Southeast Asian J Trop Med Public Health; 1980 Dec; 11(4):528-31. PubMed ID: 7013095 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic results in opisthorchiasis with praziquantel in a reinfection-free environment in France. Ambroise-Thomas P; Goullier A; Peyron F Arzneimittelforschung; 1984; 34(9B):1177-9. PubMed ID: 6542388 [TBL] [Abstract][Full Text] [Related]
7. High efficacy of praziquantel in the treatment of 22 patients with Clonorchis/Opisthorchis infections. Horstmann RD; Feldheim W; Feldmeier H; Dietrich M Tropenmed Parasitol; 1981 Sep; 32(3):157-60. PubMed ID: 7345680 [TBL] [Abstract][Full Text] [Related]
8. Clinical field trial of praziquantel in opisthorchiasis in Nong Rangya Village, Khon Kaen Province, Thailand. Viravan C; Bunnag D; Harinasuta T; Upatham S; Kurathong S; Viyanant V Southeast Asian J Trop Med Public Health; 1986 Mar; 17(1):63-6. PubMed ID: 3738609 [TBL] [Abstract][Full Text] [Related]
9. [The first trial of treating opisthorchiasis with the Soviet preparation azinoks]. Stepanova TF; Pomigalov AIu; Shonin AL; Postnikova TF; Emel'ianova ED; Maĭer VA; Skarednov NI Med Parazitol (Mosk); 1991; (6):30-2. PubMed ID: 1818244 [TBL] [Abstract][Full Text] [Related]
10. [An analysis of 4 strategies for the praziquantel treatment of persons infested with Opisthorchis felineus under conditions excluding reinfestation]. Bronshteĭn AM; Ozeretskovskaia NN; Panteleeva EIa; Pliushcheva GL; Gitsu GA Med Parazitol (Mosk); 1988; (5):19-24. PubMed ID: 3252134 [No Abstract] [Full Text] [Related]
11. [The procedure for the wide use of praziquantel in a complex of measures to control opisthorchiasis. 1. The tolerance and efficacy of different doses of biltricide during outpatient use in foci]. Zavoĭkin VD; Zelia OP; Bronshteĭn AM; Sokerina OA; Iarotskiĭ LS; Firsova RA; Mikhaĭlov MM; Gerasimov IV Med Parazitol (Mosk); 1994; (3):24-7. PubMed ID: 7799850 [TBL] [Abstract][Full Text] [Related]
12. Praziquantel side effects during treatment of Schistosoma mansoni infected pupils in Kibwezi, Kenya. Jaoko WG; Muchemi G; Oguya FO East Afr Med J; 1996 Aug; 73(8):499-501. PubMed ID: 8898462 [TBL] [Abstract][Full Text] [Related]
13. Studies on the chemotherapy of human opisthorchiasis: II. Clinical trial of niclofolan. Bunnag D; Harinasuta T; Desakorn V Southeast Asian J Trop Med Public Health; 1981 Mar; 12(1):107-9. PubMed ID: 7020093 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of praziquantel in patients with opisthorchiasis. Na Bangchang K; Karbwang J; Pungpak S; Radomyos B; Bunnag D Southeast Asian J Trop Med Public Health; 1993 Dec; 24(4):717-23. PubMed ID: 7939947 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of tribendimidine versus praziquantel against Opisthorchis viverrini in Laos: an open-label, randomised, non-inferiority, phase 2 trial. Sayasone S; Keiser J; Meister I; Vonghachack Y; Xayavong S; Senggnam K; Phongluxa K; Hattendorf J; Odermatt P Lancet Infect Dis; 2018 Feb; 18(2):155-161. PubMed ID: 29153938 [TBL] [Abstract][Full Text] [Related]
16. Efficacious and safe dose of praziquantel for the successful treatment of feline reservoir hosts with opisthorchiasis. Sereerak P; Upontain S; Tangkawattana P; Mallory FF; Sripa B; Tangkawattana S Parasitol Int; 2017 Aug; 66(4):448-452. PubMed ID: 27576001 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, tribendimidine, and praziquantel in patients with Opisthorchis viverrini: a randomised, exploratory, open-label, phase 2 trial. Soukhathammavong P; Odermatt P; Sayasone S; Vonghachack Y; Vounatsou P; Hatz C; Akkhavong K; Keiser J Lancet Infect Dis; 2011 Feb; 11(2):110-8. PubMed ID: 21111681 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of Opisthorchis viverrini infection among villagers harboring Opisthorchis-like eggs. Sukontason KL; Sukontason K; Piangjai S; Pungpak S; Radomyos P Southeast Asian J Trop Med Public Health; 2001; 32 Suppl 2():23-6. PubMed ID: 12041596 [TBL] [Abstract][Full Text] [Related]
19. [Differences in the dynamics of the eosinophilia, blood immunoglobulin E and the level of circulating immune complexes in patients with chronic opisthorchiasis treated with different doses of praziquantel]. Legon'kov IuA; Ozeretskovskaia NN; Gervazieva VB; Ovsiannikova IG; Bronshteĭn AM Med Parazitol (Mosk); 1992; (5-6):19-21. PubMed ID: 1299753 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Praziquantel Against Light Infections of Opisthorchis viverrini: A Randomized Parallel Single-Blind Dose-Ranging Trial. Sayasone S; Meister I; Andrews JR; Odermatt P; Vonghachack Y; Xayavong S; Senggnam K; Phongluxa K; Hattendorf J; Bogoch II; Keiser J Clin Infect Dis; 2017 Feb; 64(4):451-458. PubMed ID: 28174906 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]